AG真人官方

IonQ Form 144 summary: This notice reports that 85,510 shares of IonQ common stock, acquired on 08/14/2025 upon vesting of equity awards, are proposed for sale through E-TRADE on or about 08/15/2025. The filing shows the company has 296,841,308 shares outstanding and places an aggregate market value on the planned sale of $3,523,868. The filer also disclosed multiple recent sales by the same person during June 2025 totaling several million shares with gross proceeds of approximately $228,225,951.06 across four transactions. The filer attests there is no undisclosed material adverse information.

IonQ, Inc. (IONQ) disclosure shows an insider, Inder Singh, proposes to sell 50,480 common shares through Morgan Stanley Smith Barney with an aggregate market value of $2,171,801.04. The shares were acquired by exercise of options under a registered plan (components: 2,050; 33,570; 14,860), and the proposed sale represents about 0.017% of the 296,837,796 shares outstanding. The filing lists prior sales in the past three months totaling 80,481 shares for gross proceeds of $3,117,335.44 (sales on 06/12/2025 and 08/01/2025). The notice includes the required representation that the seller is not aware of undisclosed material adverse information and references Rule 144 procedures.

IonQ, Inc. (IONQ) filed a prospectus supplement registering the resale by selling stockholders of up to 13,220,367 shares of common stock. The company will receive no proceeds from these sales. As of August 5, 2025, there were 296,841,308 shares outstanding and the last reported NYSE sale price was $42.02 per share on August 5, 2025.

The supplement discloses detailed selling stockholder positions (including institutional holders such as SK Square and USIT Holdco), escrowed shares related to the ID Quantique acquisition (including 902,160 escrowed shares), and a specified director/officer lock-up period from July 7, 2025 through September 5, 2025. The filing reiterates the companys recent operating losses of $209.1 million and $77.2 million for the six months ended June 30, 2025 and 2024, respectively, and an accumulated deficit of $892.8 million as of June 30, 2025.

IonQ, Inc. filed a prospectus supplement to its Form S-3ASR registration statement (File No. 333-285279) covering the resale by certain selling stockholders of 13,220,367 shares of common stock. A legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP is filed as Exhibit 5.1 and the firm's consent is included as Exhibit 23.1. The filing also includes the cover page interactive data file as Exhibit 104. The prospectus supplement and attached opinion are incorporated by reference into the registration statement to register the resale of the specified shares.

Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. reported the sale of 537,880 shares of common stock on 08/06/2025 pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. The reported weighted average sale price was $41.2804, with individual trades ranging from $40.88 to $43.00. Following these transactions, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.

The Form 4 discloses the sale activity and includes an undertaking to provide details on the number of shares sold at each price within the disclosed range upon request.